Your browser doesn't support javascript.
loading
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses.
Odunsi, Kunle; Qian, Feng; Lugade, Amit A; Yu, Han; Geller, Melissa A; Fling, Steven P; Kaiser, Judith C; Lacroix, Andreanne M; D'Amico, Leonard; Ramchurren, Nirasha; Morishima, Chihiro; Disis, Mary L; Dennis, Lucas; Danaher, Patrick; Warren, Sarah; Nguyen, Van Anh; Ravi, Sudharshan; Tsuji, Takemasa; Rosario, Spencer; Zha, Wenjuan; Hutson, Alan; Liu, Song; Lele, Shashikant; Zsiros, Emese; McGray, A J Robert; Chiello, Jessie; Koya, Richard; Chodon, Thinle; Morrison, Carl D; Putluri, Vasanta; Putluri, Nagireddy; Mager, Donald E; Gunawan, Rudiyanto; Cheever, Martin A; Battaglia, Sebastiano; Matsuzaki, Junko.
Affiliation
  • Odunsi K; University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, USA.
  • Qian F; Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, USA.
  • Lugade AA; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Yu H; University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, USA.
  • Geller MA; Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, USA.
  • Fling SP; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Kaiser JC; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Lacroix AM; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • D'Amico L; Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, MN, USA.
  • Ramchurren N; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Morishima C; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Disis ML; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Dennis L; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Danaher P; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Warren S; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Nguyen VA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
  • Ravi S; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Tsuji T; NanoString Technologies Inc., Seattle, WA, USA.
  • Rosario S; NanoString Technologies Inc., Seattle, WA, USA.
  • Zha W; NanoString Technologies Inc., Seattle, WA, USA.
  • Hutson A; Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.
  • Liu S; Department of Chemical and Biological Engineering, University at Buffalo, State University of New York, Buffalo, NY, USA.
  • Lele S; University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, USA.
  • Zsiros E; Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, USA.
  • McGray AJR; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Chiello J; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Koya R; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Chodon T; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Morrison CD; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Putluri V; Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Putluri N; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Mager DE; Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Gunawan R; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Cheever MA; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Battaglia S; University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, USA.
  • Matsuzaki J; Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, USA.
Sci Transl Med ; 14(636): eabg8402, 2022 03 16.
Article in En | MEDLINE | ID: mdl-35294258
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Indoleamine-Pyrrole 2,3,-Dioxygenase Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Sci Transl Med Journal subject: CIENCIA / MEDICINA Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Indoleamine-Pyrrole 2,3,-Dioxygenase Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Sci Transl Med Journal subject: CIENCIA / MEDICINA Year: 2022 Type: Article Affiliation country: United States